Dorian LPG
LPG
DOMINOS PIZZA ENTERPRISES LIMITED UNSP ADR EACH REPR 0.5 ORD SHS
DMZPY
AIRPORTS OF THAILAND PUBLIC CO UNSP ADR EACH REP 10 ORD SHS
AIPUY
eBay
EBAY
Lantheus
LNTH
US Stock MarketDetailed Quotes
SER Serina Therapeutics
- 6.130
- +1.340+27.97%
Close Dec 18 16:00 ET
- 6.340
- +0.210+3.43%
Post 19:21 ET
57.57MMarket Cap-102.17P/E (TTM)
6.490High4.510Low149.94KVolume4.510Open4.790Pre Close865.96KTurnover4.30%Turnover RatioLossP/E (Static)9.39MShares22.82552wk High-4.18P/B21.36MFloat Cap3.81052wk Low--Dividend TTM3.48MShs Float209.262Historical High--Div YieldTTM41.34%Amplitude3.810Historical Low5.775Avg Price1Lot Size
About Serina Therapeutics Company
Serina Therapeutics, Inc. operates as a pharmaceutical company, which engages in the development of polymer technology. Its POZ technology is designed to optimize drug delivery to maximize compliance, therapeutic outcomes, safety, and quality of life for patients. It also offers drugs to treat neurological diseases, cancer, and pain. The company was founded by J. Milton Harris and Michael D. Bentley on March 26, 2024 and is headquartered in Huntsville, AL.
Company Profile
SymbolSER
Company NameSerina Therapeutics
Listing DateNov 29, 2018
Founded2024
CEOMr. Steven Ledger
MarketAMEX
Fiscal Year Ends12-31
Address601 Genome Way,Suite 2001
CityHuntsville
ProvinceAlabama
CountryUnited States of America
Zip Code35806
Phone1-256-327-9630
Company Executives
- Name
- Position
- Salary
- Steven Ledger
- Director and Chief Executive Officer
- 237.50K
- Dr. Randall W. Moreadith,M.D.,PhD
- Chief Development Officer
- 433.88K
- Gregory S. Curhan
- Chief Financial Officer
- --
- Dr. Srini Tenjarla, PhD
- Senior Vice President, CMC and Formulation
- --
- Dr. Balkrishan Gill, PhD
- Executive Chairman of the Board
- --
- Dr. Simba Gill, PhD
- Chairman of the Board
- --
- J. Milton Harris, PhD
- Independent Director
- --
- Dr. Richard Marshall, M.D.
- Independent Director
- --
- Remy Gross
- Independent Director
- --
- Steven M. Mintz
- Independent Director
- --
